Danaher Corp. closed 33.68% short of its 52-week high of $281.70, which the company achieved on August 1st.

Buying $100 In DHR: If an investor had bought $100 of DHR stock 10 years ago, it would be worth $326.41 today based on a ...

We recently published a list of 10 Best Medical Stocks to Buy According to Billionaires. In this article, we are going to ...

Andvari Associates, an investment management firm, released its first-quarter 2025 investor letter. A copy of the letter can ...

Baird analyst Catherine Ramsey Schulte lowered the firm’s price target on Danaher (DHR) to $231 from $258 and keeps an Outperform rating on the ...

Danaher Corp. closed 33.00% below its 52-week high of $281.70, which the company achieved on August 1st.

Whales with a lot of money to spend have taken a noticeably bullish stance on Danaher. Looking at options history for Danaher ...

BofA lowered the firm’s price target on Danaher (DHR) to $230 from $265 and keeps a Buy rating on the shares. Sentiment for Life Sciences and ...

DHR is poised to gain from strength in the clinical diagnostics business, the Abcam buyout and shareholder-friendly policies.

Danaher Corporation incorporates science and technology and has a market cap of $150B. The company has mixed financials, with its gross profit margin being its strongest and most consistent.

In this article, we are going to take a look at where Danaher Corporation (NYSE:DHR) stands against other best medical stocks to buy according to billionaires. Some experts view medical ...